Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

Roche’s Vabysmo showed extended durability, continued efficacy and a consistent safety profile in long-term diabetic macular edema (DME) study

F. Hoffmann-La Roche Ltd More than 90% of patients had absence of DME after four years in a pre-specified exploratory endpoint People treated with Vabysmo sustained vision gains and anatomical improvements, with almost 80% receiving treatment at intervals of three or four months, in …

EODHD | 17 July 2024

RUBIS: Rubis Énergie signs a master shelf facility subscription agreement for USD 265 million

Rubis Paris, 17 July 2024, 5:45pm CET Rubis announces today that its subsidiary Rubis Énergie SAS has signed its first-ever US Private Placement (USPP) financing under French law, with PGIM Private Capital (“PPC”) the private capital arm of PGIM Inc., the global investment management …

EODHD | 17 July 2024

VALE's Q2 Iron Ore Output Up 2% Y/Y, Copper and Nickel Lags

Vale S.A. VALE reported iron ore production of 80.6 million tons (Mt) for the second quarter of 2024, which was up 2% year over year, attributed to improved operating performance at the S11D and Vargem Grande. During the quarter, the S11D mine delivered record …

EODHD | 17 July 2024

Genentech’s Vabysmo Showed Extended Durability, Continued Efficacy and a Consistent Safety Profile in Long-Term Diabetic Macular Edema (DME) Study

– More than 90% of patients had absence of DME after four years in a pre-specified exploratory endpoint – – People treated with Vabysmo sustained vision gains and anatomical improvements, with almost 80% receiving treatment at intervals of three or four months, in an …

EODHD | 17 July 2024

Ex-Goldman Sachs Associate Gets 28 Months in Insider Trading Case

(Bloomberg) -- A former Goldman Sachs Group Inc. associate will spend 28 months behind bars after admitting to passing inside tips to friends while working at the investment bank and Blackstone Inc. Most Read from Bloomberg US Floats Stricter Trade Rules to Rein In …

EODHD | 17 July 2024

CMS vs. NEE: Which Stock Is the Better Value Option?

Investors interested in Utility - Electric Power stocks are likely familiar with CMS Energy (CMS) and NextEra Energy (NEE). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. There …

EODHD | 17 July 2024

BTG vs. FNV: Which Stock Is the Better Value Option?

Investors interested in Mining - Gold stocks are likely familiar with B2Gold (BTG) and Franco-Nevada (FNV). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. The best way to find great value …

EODHD | 17 July 2024

ICLR vs. GDRX: Which Stock Is the Better Value Option?

Investors with an interest in Medical Services stocks have likely encountered both Icon PLC (ICLR) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have …

EODHD | 17 July 2024

TLK vs. TU: Which Stock Is the Better Value Option?

Investors looking for stocks in the Diversified Communication Services sector might want to consider either PT Telekomunikasi (TLK) or Telus (TU). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. There …

EODHD | 17 July 2024

FSLR or ENPH: Which Is the Better Value Stock Right Now?

Investors with an interest in Solar stocks have likely encountered both First Solar (FSLR) and Enphase Energy (ENPH). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that …

EODHD | 17 July 2024
Support

Hi! How can we help you today?

Loading…